Targeting mitophagy-related genes like PINK1 and PRKN could potentially sensitize cancer cells to treatment by promoting the accumulation of dysfunctional mitochondria, thereby increasing oxidative stress and cell death. This evidence concerns the gene PINK1 and cancer.